Home > Boards > US Listed > Biotechs > Seres Therapeutics (MCRB)

My $11 target almost reach. I'm out $$$

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
MARINO Member Profile
 
Followed By 150
Posts 15,397
Boards Moderated 0
Alias Born 10/25/06
160x600 placeholder
Seres Therapeutics Expands Executive Team with Appointments of David S. Ege, Ph.D., as Chief Technology Officer & Jayne M. Ga... Business Wire - 10/22/2020 7:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/21/2020 5:00:59 PM
Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results at American College of Gastroenterology Annual Scient... Business Wire - 10/12/2020 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/9/2020 2:17:46 PM
Seres Therapeutics to Present at the Jefferies Next Generation IBD Therapeutics Summit Business Wire - 9/22/2020 7:00:00 AM
Seres Therapeutics to Present at Upcoming Investor Conferences Business Wire - 9/14/2020 7:00:00 AM
Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results Business Wire - 9/11/2020 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/10/2020 10:04:08 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/9/2020 6:05:05 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/8/2020 1:29:25 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/19/2020 5:18:18 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/17/2020 4:22:24 PM
Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock Business Wire - 8/17/2020 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2020 5:10:13 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/14/2020 5:07:09 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/14/2020 5:04:39 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/13/2020 6:06:59 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/13/2020 6:01:38 AM
Seres Therapeutics, Inc. Announces Pricing of Public Offering of 10,500,000 Shares of Common Stock Business Wire - 8/12/2020 9:39:00 PM
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock Business Wire - 8/11/2020 5:48:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/11/2020 5:31:17 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 8/11/2020 5:12:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 7:32:26 AM
Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infect... Business Wire - 8/10/2020 6:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/28/2020 10:02:53 AM
MARINO   Friday, 08/12/16 10:17:59 AM
Re: None
Post # of 156 
My $11 target almost reach. I'm out $$$

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences